WHO ICTRP trial
A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19
IRCT20151228025732N52 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20151228025732N52 |
|---|---|
| Public title | A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19 |
| Scientific title | A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19 hospitalized in intensive care unit of Semnan Kowsar Hopsital |
| Primary sponsor | Semnan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Covid-19. Covid-19 infection;U07.01 |
| Interventions | Intervention 1: Intervention group: In addition to national protocol medications, patients receive 40 mg of melatonin (Simorgh Pharmaceutical Company); (2 tablets, 5 mg every 6 hours) via NG tube. Patients will also receive 2 grams of… |
| Registration date | Apr 9, 2020 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: